These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 8142312)
1. Inhibition of the activity of 'basic' 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells. Délos S; Iehlé C; Martin PM; Raynaud JP J Steroid Biochem Mol Biol; 1994 Mar; 48(4):347-52. PubMed ID: 8142312 [TBL] [Abstract][Full Text] [Related]
2. Human prostatic steroid 5 alpha-reductase isoforms--a comparative study of selective inhibitors. Iehlé C; Délos S; Guirou O; Tate R; Raynaud JP; Martin PM J Steroid Biochem Mol Biol; 1995 Sep; 54(5-6):273-9. PubMed ID: 7577710 [TBL] [Abstract][Full Text] [Related]
3. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. Délos S; Carsol JL; Ghazarossian E; Raynaud JP; Martin PM J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):375-83. PubMed ID: 8541234 [TBL] [Abstract][Full Text] [Related]
4. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325 [TBL] [Abstract][Full Text] [Related]
5. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells. Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J J Androl; 2003; 24(5):681-7. PubMed ID: 12954658 [TBL] [Abstract][Full Text] [Related]
6. Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells. Kaefer M; Audia JE; Bruchovsky N; Goode RL; Hsiao KC; Leibovitch IY; Krushinski JH; Lee C; Steidle CP; Sutkowski DM; Neubauer BL J Steroid Biochem Mol Biol; 1996 May; 58(2):195-205. PubMed ID: 8809201 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture. Berthaut I; Mestayer C; Portois MC; Cussenot O; Mowszowicz I Prostate; 1997 Aug; 32(3):155-63. PubMed ID: 9254894 [TBL] [Abstract][Full Text] [Related]
9. In vivo assay for conversion of testosterone to dihydrotestosterone by rat prostatic steroid 5 alpha-reductase and comparison of two inhibitors. Toomey RE; Goode RL; Petrow V; Neubauer BL Prostate; 1991; 19(1):63-72. PubMed ID: 1876537 [TBL] [Abstract][Full Text] [Related]
10. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1. Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478 [TBL] [Abstract][Full Text] [Related]
11. Four-amino acid segment in steroid 5 alpha-reductase 1 confers sensitivity to finasteride, a competitive inhibitor. Thigpen AE; Russell DW J Biol Chem; 1992 Apr; 267(12):8577-83. PubMed ID: 1314830 [TBL] [Abstract][Full Text] [Related]
12. 6-Azasteroids: potent dual inhibitors of human type 1 and 2 steroid 5 alpha-reductase. Frye SV; Haffner CD; Maloney PR; Mook RA; Dorsey GF; Hiner RN; Batchelor KW; Bramson HN; Stuart JD; Schweiker SL J Med Chem; 1993 Dec; 36(26):4313-5. PubMed ID: 8277514 [No Abstract] [Full Text] [Related]
13. 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate. Délos S; Carsol JL; Fina F; Raynaud JP; Martin PM Int J Cancer; 1998 Mar; 75(6):840-6. PubMed ID: 9506528 [TBL] [Abstract][Full Text] [Related]
14. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Bartsch G; Rittmaster RS; Klocker H Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065 [TBL] [Abstract][Full Text] [Related]
15. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor. di Salle E; Giudici D; Radice A; Zaccheo T; Ornati G; Nesi M; Panzeri A; Délos S; Martin PM J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412 [TBL] [Abstract][Full Text] [Related]
16. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia. Habib FK; Ross M; Tate R; Chisholm GD Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat. Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729 [TBL] [Abstract][Full Text] [Related]
18. A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride. Gisleskog PO; Hermann D; Hammarlund-Udenaes M; Karlsson MO Clin Pharmacol Ther; 1998 Dec; 64(6):636-47. PubMed ID: 9871428 [TBL] [Abstract][Full Text] [Related]
19. Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes. Thigpen AE; Cala KM; Russell DW J Biol Chem; 1993 Aug; 268(23):17404-12. PubMed ID: 8394341 [TBL] [Abstract][Full Text] [Related]
20. Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues. Fouad Mansour M; Pelletier M; Tchernof A J Steroid Biochem Mol Biol; 2016 Jul; 161():45-53. PubMed ID: 26855069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]